FALZARANO, Maria Sofia
 Distribuzione geografica
Continente #
NA - Nord America 7.086
AS - Asia 3.776
EU - Europa 3.015
SA - Sud America 688
AF - Africa 94
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.721
Nazione #
US - Stati Uniti d'America 6.866
SG - Singapore 1.443
CN - Cina 922
PL - Polonia 767
IT - Italia 616
BR - Brasile 554
VN - Vietnam 430
DE - Germania 427
HK - Hong Kong 293
UA - Ucraina 268
GB - Regno Unito 254
TR - Turchia 201
FI - Finlandia 127
FR - Francia 127
CA - Canada 111
JP - Giappone 108
RU - Federazione Russa 104
IN - India 98
SE - Svezia 95
MX - Messico 78
ID - Indonesia 62
AR - Argentina 54
NL - Olanda 51
AU - Australia 46
BD - Bangladesh 40
ZA - Sudafrica 40
BE - Belgio 39
ES - Italia 37
PK - Pakistan 31
IQ - Iraq 30
CO - Colombia 21
CZ - Repubblica Ceca 19
MA - Marocco 17
LT - Lituania 16
CL - Cile 15
VE - Venezuela 15
PH - Filippine 14
NZ - Nuova Zelanda 13
RO - Romania 11
UZ - Uzbekistan 11
CH - Svizzera 10
EC - Ecuador 10
MY - Malesia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
IE - Irlanda 9
TH - Thailandia 9
AT - Austria 8
EG - Egitto 7
KE - Kenya 7
BO - Bolivia 6
CR - Costa Rica 6
JO - Giordania 6
KR - Corea 6
NP - Nepal 6
PE - Perù 6
IL - Israele 5
PT - Portogallo 5
TN - Tunisia 5
AZ - Azerbaigian 4
EE - Estonia 4
JM - Giamaica 4
KZ - Kazakistan 4
LB - Libano 4
QA - Qatar 4
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SV - El Salvador 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
ET - Etiopia 2
GD - Grenada 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
Totale 14.702
Città #
Singapore 890
Ashburn 859
Warsaw 764
Fairfield 605
Woodbridge 517
San Jose 405
Ann Arbor 360
Houston 359
Chandler 355
Beijing 341
Jacksonville 289
Santa Clara 289
Hong Kong 278
Seattle 233
Wilmington 219
Cambridge 180
Los Angeles 141
Dallas 140
New York 133
Ho Chi Minh City 120
Munich 106
Hanoi 103
Izmir 98
Nanjing 91
Tokyo 91
Milan 87
Ferrara 80
Princeton 74
Boardman 65
Lauterbourg 62
Shanghai 59
São Paulo 58
Council Bluffs 53
Orem 52
San Diego 52
Mexico City 46
Rome 46
Brescia 45
Dong Ket 44
Bremen 43
Helsinki 40
London 40
Brussels 39
Jakarta 39
Montreal 39
Johannesburg 33
Addison 31
Buffalo 31
Turku 31
Brooklyn 30
Toronto 30
Chennai 29
Chicago 29
Hefei 29
Stockholm 29
Tianjin 29
The Dalles 28
Denver 27
Phoenix 25
Sydney 25
Frankfurt am Main 24
Poplar 23
Shenyang 22
Atlanta 21
Nanchang 21
Boston 19
Da Nang 19
Jinan 19
Bologna 18
Changsha 18
Moscow 18
Hebei 17
Brno 15
Dearborn 15
Jiaxing 15
Haiphong 14
Mumbai 13
Nuremberg 13
Auburn Hills 12
Manchester 12
Norwalk 12
Perth 12
Rio de Janeiro 12
Brasília 11
Querétaro 11
San Francisco 11
Wan Chai 11
Zhengzhou 11
Amsterdam 10
Ankara 10
Baghdad 10
Biên Hòa 10
Charlotte 10
Curitiba 10
Falls Church 10
Florence 10
Hamilton 10
Redwood City 10
Columbus 9
Dublin 9
Totale 10.022
Nome #
Duchenne muscular dystrophy: From diagnosis to therapy 546
Meccanismi del danno neuronale indotto dalla tossina mitocondriale sodio azide in colture primarie di corteccia di ratto. Effetti sulle Protein Kinasi C. 477
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 468
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 409
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 340
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease 317
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 306
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 274
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 269
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 268
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 261
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature 259
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 256
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 248
Exon skipping-mediated dystrophin reading frame restoration for small mutations 238
Sodium Azide Induced Neuronal Damage In Vitro: Evidence for Non-Apoptotic Cell Death 232
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 229
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 220
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 219
Biodistribution Studies of Polymeric Nanoparticles for Drug Delivery in Mice. 210
Sodium azide: a useful tool for in vitro studying neurodegenerative diseases. 210
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family 209
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 206
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 205
Spatial RNA-mapping reveals the unique patterns of expression and localisation of dystrophin isoforms in the human adult normal brain to improve understanding of brain involvement in muscular dystrophy 199
Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices 198
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 193
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 188
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 184
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 184
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 183
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 181
Physical and transcriptional characterization of human urinary stem cell populations 181
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 180
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 175
RNAseq in urine-derived stem cells identified the expression of 308 neuromuscular gene transcripts [NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.384] 175
null 172
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 172
Protective effect of a peptide derived from the endogenous PKC inhibitor PKI55 on the neurosecretory function in ischemic brain slices 172
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 170
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for duchenne muscular dystrophy. 168
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 167
Oligomeric formylpeptide activity on human neutrophils 165
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 164
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 162
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 162
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 158
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 157
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 156
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 156
Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4 155
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 155
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 154
Protein kinase C isoforms changes induced by chemical ischemia-reperfusion in rat cerebral cortex slices 152
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 151
Nanodiagnostics and nanodelivery applications in genetic alterations 151
Nanoparticles to deliver antisense oligonucleotides aimed at exon skipping therapies 140
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 139
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 132
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 126
MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping 122
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 119
Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases 118
null 113
Effects of chemical ischemia on cerebral cortex slices: focus on mitogen-activated protein kinase cascade. 111
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 110
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 108
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 107
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 106
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 104
Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. 97
null 96
null 94
new pyrazolyl ureas as potent human neutrophil chemotaxis inhibitors 93
null 92
null 92
null 90
null 87
null 80
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils 72
Totale 14.864
Categoria #
all - tutte 57.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 720
Totale 58.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021337 0 0 0 0 0 0 0 0 0 138 111 88
2021/2022840 31 101 58 27 28 26 62 45 33 53 124 252
2022/2023853 79 80 25 112 165 110 48 58 80 15 53 28
2023/2024582 44 45 40 16 27 104 31 52 22 18 13 170
2024/20252.198 47 36 161 115 263 227 130 108 350 258 264 239
2025/20265.447 624 267 496 829 970 370 649 270 427 545 0 0
Totale 14.864